Semaglutide Injection 0.25 mg / 0.5 mL

Semaglutide Injection 0.25 mg / 0.5 mL is a semaglutide-based injectable formulation supplied in a convenient pre-filled pen. It is intended for subcutaneous administration under the direction and supervision of a qualified healthcare professional.

Semaglutide is a GLP-1 receptor agonist used as part of an appropriate treatment plan for eligible patients. The 0.25 mg strength is associated with the initial dosing stage of approved semaglutide weight-management therapy, where applicable.

Farlex Semaglutide Injection 0.25 mg / 0.5 mL is presented in a pre-filled pen format designed for convenient administration as prescribed.

Composition: Semaglutide Injection 0.25 mg / 0.5 mL
Packing: 1 Pre-filled Pen
Route of Administration: Subcutaneous